Dutasteride



Dutasteride





(du tas’ teh ride)

AvodartDNC

PREGNANCY CATEGORY X


Drug Classes

Androgen hormone inhibitor

BPH drug


Therapeutic Actions

Inhibits the intracellular enzyme (5 alpha-reductase) that converts testosterone into a potent androgen (DHT); does not affect androgen receptors in the body; the prostate gland is dependent on DHT for its development and maintenance.


Indications



  • Treatment of symptomatic BPH in men with an enlarged prostate gland


  • In combination with tamsulosin for treatment of symptomatic BPH in men with enlarged prostate gland


  • Unlabeled use: Prostate cancer prevention.



Available Forms

CapsuleDNC—0.5 mg


Dosages

Adults

0.5 mg/day PO. Swallow whole.



  • Combination therapy with tamsulosin: 0.5 mg/day PO with tamsulosin 0.4. mg/day PO.

Pediatric patients

Contraindicated in pediatric patients.


Pharmacokinetics















Route Peak Duration
Oral 2–3 hr Unknown

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 20, 2016 | Posted by in NURSING | Comments Off on Dutasteride

Full access? Get Clinical Tree

Get Clinical Tree app for offline access